Here are four things to know:
1. The GI sealant is designed to minimize staple-line leakage in gastrointestinal resection procedures.
2. The FDA trial will be a multi-center, multinational, randomized, double-arm, single-blind study.
3. There will be study sites in both the Unites States and Europe.
4. The LifeSeal Surgical Sealant Kit has received the CE Mark.
More articles on GI/endoscopy:
Surveillance endoscopy improves esophageal cancer outcomes in Barrett’s esophagus patients: 3 insights
Small bowel resection inpatient costs total $28.5k & 7 more statistics
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
